Neotropix
Latest round
- Series B
Last raised
- May 2009
Total raised
- $14M
Investors
- 3
About Neotropix
Founded in 2003, Neotropix is a biotechnology company, develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers.
Who invested in Neotropix
3 investors across 4 rounds
See all investors in Neotropix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neotropix
Who invested in Neotropix?
Neotropix has 3 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neotropix raised?
Neotropix has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Neotropix last raise money?
Neotropix's most recent round on record is a Series B, in May 2009.
What does Neotropix do?
Founded in 2003, Neotropix is a biotechnology company, develops and commercializes systemically deliverable oncolytic viruses for the treatment of neuroendocrine cancers.
Where is Neotropix headquartered?
Neotropix is headquartered in Malvern, US.
Which VCs invest in companies like Neotropix?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Neotropix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Neotropix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.